Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254

Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267

Factors associated with COVID-19-related death using OpenSAFELY

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481

Attributes and predictors of long COVID

Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Cummings, M. J., Baldwin, M. R., Abrams, D. C., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,245

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Zhu, L., She, Z., Cheng, X., Qin, J., Zhang, X.-J., Cai, J., Lei, F., Wang, H., Xie, J., Wang, W., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.021 · Cited by 1,638

Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes

Segerstolpe, Å., Palasantza, A., Eliasson, P., Andersson, E.-M., Andréasson, A.-C., Sun, X., Picelli, S., Sabirsh, A., Clausen, M., Bjursell, M. K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.020 · Cited by 1,550

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Daly, J. L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M. K., Antón-Plágaro, C., Shoemark, D. K., Simón-Gracia, L., Bauer, M., Hollandi, R., et al. (2020) · Science · doi:10.1126/science.abd3072 · Cited by 1,251

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Spinner, C. D., Gottlieb, R., Criner, G. J., Arribas, J. R., Cattelan, A. M., Soriano, À., Ogbuagu, O. E., Malhotra, P., Mullane, K. M., Castagna, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.16349 · Cited by 1,234

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Lim, S. K., Bae, J. H., Kwon, H., & Nauck, M. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,061

The protein expression profile of ACE2 in human tissues

Hikmet, F., Méar, L., Edvinsson, Å., Micke, P., Uhlén, M., & Lindskog, C. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209610 · Cited by 1,016

Practical recommendations for the management of diabetes in patients with COVID-19

Bornstein, S. R., Rubino, F., Khunti, K., Mingrone, G., Hopkins, D., Birkenfeld, A. L., Boehm, B. O., Amiel, S. A., Holt, R. I. G., Skyler, J. S., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30152-2 · Cited by 975

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

Barron, E., Bakhai, C., Kar, P. S., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K. K., Sattar, N. A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30272-2 · Cited by 951

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Holman, N., Knighton, P., Kar, P., O'Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C., Khunti, K., Wareham, N. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30271-0 · Cited by 908

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Rodrigues, T. S., de Sá, K. S. G., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201707 · Cited by 839

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Cariou, B., Hadjadj, S., Wargny, M., Pichelin, M., Al‐Salameh, A., Allix, I., Amadou, C., Arnault, G., Baudoux, F., Bauduceau, B., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05180-x · Cited by 834

Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the united states

Bode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766

Obesity, eating behavior and physical activity during COVID-19 lockdown: A study of UK adults

Robinson, E., Boyland, E. J., Chisholm, A., Harrold, J. A., Maloney, N. G., Marty, L., Mead, B. R., Noonan, R. J., & Hardman, C. A. (2020) · Appetite · doi:10.1016/j.appet.2020.104853 · Cited by 754

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

Codo, A. C., Davanzo, G. G., Monteiro, L. D. B., de Souza, G. F., Muraro, S. P., Virgilio-da-Silva, J. V., Prodonoff, J. S., Carregari, V. C., de Biagi Junior, C. A. O., Crunfli, F., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.007 · Cited by 733

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

Yang, L., Han, Y., Nilsson-Payant, B. E., Gupta, V., Wang, P., Duan, X., Tang, X., Zhu, J., Zhao, Z., Jaffré, F., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.015 · Cited by 645

Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study

Carey, I. M., Critchley, J., DeWilde, S., Harris, T. J., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 636

Obesity is associated with impaired immune response to influenza vaccination in humans

Sheridan, P. A., Paich, H. A., Handy, J., Karlsson, E. A., Hudgens, M. G., Sammon, A. B., Holland, L., Weir, S. S., Noah, T. L., & Beck, M. A. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.208 · Cited by 605

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Wei, J., Alfajaro, M. M., DeWeirdt, P. C., Hanna, R. E., Lu-Culligan, W. J., Cai, W. L., Strine, M. S., Zhang, S.-M., Graziano, V. R., Schmitz, C. O., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.028 · Cited by 572

Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns

Enge, M., Arda, H. E., Mignardi, M., Beausang, J., Bottino, R., Kim, S. K., & Quake, S. R. (2017) · Cell · doi:10.1016/j.cell.2017.09.004 · Cited by 568

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

Daniloski, Z., Jordan, T. X., Wessels, H., Hoagland, D. A., Kasela, S., Legut, M., Maniatis, S., Mimitou, E. P., Lu, L., Geller, E. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.030 · Cited by 561

Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome

The National Heart, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401520 · Cited by 533

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Schurink, B., Roos, E., Radonic, T., Barbé, E., Bouman, C. S. C., de Boer, H. H., de Bree, G. J., Bulle, E., Aronica, E., Florquin, S., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30144-0 · Cited by 517

Single-cell analysis of human adipose tissue identifies depot- and disease-specific cell types

Vijay, J., Gauthier, M., Biswell, R. L., Louiselle, D. A., Johnston, J. J., Cheung, W., Belden, B., Pramatarova, A., Biertho, L. D., Gibson, M., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0152-6 · Cited by 478

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Zhang, X.-J., Qin, J., Cheng, X., Shen, L., Zhao, Y.-C., Yuan, Y., Lei, F., Chen, M.-M., Yang, H., Bai, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.015 · Cited by 476

COVID ‐19 infection may cause ketosis and ketoacidosis

Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 467

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

Wang, R., Simoneau, C. R., Kulsuptrakul, J., Bouhaddou, M., Travisano, K. A., Hayashi, J. M., Carlson-Stevermer, J., Zengel, J. R., Richards, C. M., Fozouni, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.12.004 · Cited by 417

Targeting innate immune mediators in type 1 and type 2 diabetes

Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416

Epigenomic plasticity enables human pancreatic α to β cell reprogramming

Bramswig, N. C., Everett, L. J., Schug, J., Dorrell, C., Liu, C., Luo, Y., Streeter, P. R., Naji, A., Grompe, M., & Kaestner, K. H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66514 · Cited by 416

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study

Critchley, J., Carey, I. M., Harris, T. J., DeWilde, S., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc18-0287 · Cited by 415

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

Chen, Y., Yang, D. L., Cheng, B., Chen, J., Peng, A., Yang, C., Liu, C., Xiong, M., Deng, A., Zhang, Y., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0660 · Cited by 409

Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications

Drucker, D. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa011 · Cited by 399

snRNA-seq reveals a subpopulation of adipocytes that regulates thermogenesis

Sun, W., Dong, H., Baláž, M., Slyper, M., Drokhlyansky, E., Colleluori, G., Giordano, A., Kovaničová, Z., Štefanička, P., Balážová, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2856-x · Cited by 363

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.

Unsworth, R., Wallace, S., Oliver, N. S., Yeung, S., Kshirsagar, A., Naidu, H., Kwong, R. M. W., Kumar, P., & Logan, K. (2020) · Diabetes Care · doi:10.2337/dc20-1551 · Cited by 363

Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis

Tsankov, B. K., Allaire, J. M., Irvine, M. A., Lopez, A., Sauve, L. J., Vallance, B. A., & Jacobson, K. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.163 · Cited by 361

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

Ioannou, G. N., Locke, E. R., Green, P. K., Berry, K., O’Hare, A. M., Shah, J. A., Crothers, K. A., Eastment, M. C., Dominitz, J. A., & Fan, V. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22310 · Cited by 355

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19

HENDREN, N. S., de Lemos, J. A., Ayers, C. R., Das, S. R., Rao, A., Carter, S. J., Rosenblatt, A., Walchok, J. G., Omar, W. A., Khera, R., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.051936 · Cited by 304

Cholesterol 25‐Hydroxylase inhibits SARS‐CoV‐2 and other coronaviruses by depleting membrane cholesterol

Wang, S., Li, W., Hui, H., Tiwari, S. K., Zhang, Q., Croker, B. A., Rawlings, S. A., Smith, D. M., Carlin, A. F., & Rana, T. M. (2020) · The EMBO Journal · doi:10.15252/embj.2020106057 · Cited by 297

Global epidemiology of type 1 diabetes in young adults and adults: a systematic review

Diaz-Valencia, P. A., Bougnères, P., & Valleron, A.-J. (2015) · BMC Public Health · doi:10.1186/s12889-015-1591-y · Cited by 294

HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry

Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Yang, X., Zhang, Y., Chen, F., Li, D., Deng, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00324-0 · Cited by 292

Patch-Seq Links Single-Cell Transcriptomes to Human Islet Dysfunction in Diabetes

Camuñas-Soler, J., Dai, X.-Q., Hang, Y., Bautista, A., Lyon, J. G., Suzuki, K., Kim, S. K., Quake, S. R., & MacDonald, P. E. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.005 · Cited by 286

Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

Bramante, C. T., Ingraham, N. E., Murray, T. A., Marmor, S., Hovertsen, S., Gronski, J., McNeil, C., Feng, R., Guzman, G., Abdelwahab, N., et al. (2020) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30033-7 · Cited by 285

Increased risk of influenza among vaccinated adults who are obese

Neidich, S. D., Green, W. D., Rebeles, J., Karlsson, E. A., Schultz‐Cherry, S., Noah, T. L., Chakladar, S., Hudgens, M. G., Weir, S. S., & Beck, M. A. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.131 · Cited by 269

Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Pollack, R. M., Donath, M. Y., LeRoith, D., & Leibowitz, G. (2016) · Diabetes Care · doi:10.2337/dcs15-3015 · Cited by 266

Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study AppPreprint

Sudre, C. H., Murray, B. A. K., Varsavsky, T., et al. (2020) · medRxiv · doi:10.1101/2020.10.19.20214494 · Cited by 259

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Solerte, S. B., D’Addio, F., Trevisan, R., Lovati, E., Rossi, A., Pastore, I., Dell’Acqua, M., Ippolito, E., Scaranna, C., Bellante, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1521 · Cited by 257

Prospective virome analyses in young children at increased genetic risk for type 1 diabetes

the TEDDY Study Group, Vehik, K., Lynch, K. F., Wong, M. C., Tian, X., Ross, M. C., Gibbs, R. A., Ajami, N. J., Petrosino, J. F., Rewers, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0667-0 · Cited by 248

Obesity increases the duration of influenza a virus shedding in adults

Maier, H. E., Lopez, R., Sanchez, N., Ng, S., Gresh, L., Ojeda, S., Burger-Calderon, R., Kuan, G., Harris, E., Balmaseda, A., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy370 · Cited by 245

Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom

Hamer, M., Galé, C. R., Mika Kivimaki, B., & Batty, G. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011086117 · Cited by 244

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

Zang, R., Case, J. B., Yutuc, E., Ma, X., Shen, S., Gomez Castro, M. F., Liu, Z., Zeng, Q., Zhao, H., Son, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012197117 · Cited by 240

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Fadini, G. P., Morieri, M. L., Boscari, F., Fioretto, P., Maran, A., Busetto, L., Bonora, B. M., Selmin, E., Arcidiacono, G. P., Pinelli, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108374 · Cited by 235

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature

Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C. A., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 219

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2021-013613 · Cited by 219

The weight of obesity on the human immune response to vaccination

Painter, S. D., Ovsyannikova, I. G., & Poland, G. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.101 · Cited by 208

Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth

Fernandes, D. M., Oliveira, C. R., Guerguis, S., Eisenberg, R. E., Choi, J., Kim, M., Abdelhemid, A., Agha, R., Agarwal, S., Aschner, J. L., et al. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.016 · Cited by 205

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

Crouse, A. B., Grimes, T., Li, P., Might, M., Ovalle, F., & Shalev, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.600439 · Cited by 194

Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19

Gupta, A., Madhavan, M. V., Poterucha, T. J., DeFilippis, E. M., Hennessey, J. A., Redfors, B., Eckhardt, C. M., Bikdeli, B., Platt, J., Nalbandian, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21553-1 · Cited by 183

SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells

Coate, K. C., Cha, J., Shrestha, S., Wang, W., Gonçalves, L. M., Almaça, J., Kapp, M., Fasolino, M., Morgan, A. R., Dai, C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.006 · Cited by 182

Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report

Hollstein, T., Schulte, D. M., Schulz, J. C., Glück, A., Ziegler, A. G., Bonifacio, E. E., Wendorff, M., Franke, A., Schreiber, S., Bornstein, S. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00281-8 · Cited by 181

Long-term COVID-19 symptoms in a large unselected populationPreprint

Cirulli, E. T., Barrett, K. M. S., Riffle, S., Bolze, A., Neveux, I., Dabe, S., Grzymski, J. J., Lu, J. T., & Washington, N. L. (2020) · medRxiv · doi:10.1101/2020.10.07.20208702 · Cited by 174

Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19

Kusmartseva, I., Wu, W., Syed, F., van der Heide, V., Jorgensen, M., Joseph, P., Tang, X., Candelario‐Jalil, E., Yang, C., Nick, H. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.005 · Cited by 173

Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study

Wang, G., Zhang, Q., Zhao, X., Dong, H., Wu, C., Wu, F., Yu, B., Lv, J., Zhang, S., Wu, G., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01382-9 · Cited by 172

Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020

Dennis, J., Mateen, B. A., Sonabend, R., Thomas, N. J. M., Patel, K. A., Hattersley, A. T., Denaxas, S., McGovern, A. P., & Vollmer, S. J. (2020) · Diabetes Care · doi:10.2337/dc20-1444 · Cited by 168

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?

Tittel, S. R., Rosenbauer, J., Kamrath, C., Ziegler, J., Reschke, F., Hammersen, J. E., Mönkemöller, K., Pappa, A., Kapellen, T. M., & Holl, R. W. (2020) · Diabetes Care · doi:10.2337/dc20-1633 · Cited by 166

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

Hoffmann, H.-H., Rivera, F. J. S., Schneider, W. M., Luna, J. M., Soto‐Feliciano, Y. M., Ashbrook, A. W., Pen, J. L., Leal, A. A., Ricardo-Lax, I., Michailidis, E., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.12.009 · Cited by 164

Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis

Leong, A., Cole, J. B., Brenner, L. N., Meigs, J. B., Florez, J. C., & Mercader, J. M. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003553 · Cited by 164

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

Cheng, X., Liu, Y.-M., Li, H., Zhang, X., Lei, F., Qin, J., Chen, Z., Deng, K., Lin, L., Chen, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.013 · Cited by 159

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

Yu, B., Li, C., Sun, Y., & Wang, D. W. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.014 · Cited by 148

Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding

Moriconi, D., Masi, S., Rebelos, E., Virdis, A., Manca, M. L., Marco, S. D., Taddei, S., & Nannipieri, M. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.05.009 · Cited by 146

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Mirani, M., Favacchio, G., Carrone, F., Betella, N., Biamonte, E., Morenghi, E., Mazziotti, G., & Lania, A. G. (2020) · Diabetes Care · doi:10.2337/dc20-1340 · Cited by 137

Diabetes Epidemiology in the COVID-19 Pandemic

Selvin, E., & Juraschek, S. P. (2020) · Diabetes Care · doi:10.2337/dc20-1295 · Cited by 132

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19

Cai, J., Li, H., Zhang, C., Chen, Z., Liu, H., Lei, F., Qin, J.-J., Liu, Y.-M., Zhou, F., Song, X., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.002 · Cited by 129

COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020

Kambhampati, A. K., O’Halloran, A. C., WHITAKER, M. D., Magill, S. S., Chea, N., Chai, S. J., Kirley, P. D., Herlihy, R., Kawasaki, B., Meek, J. I., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6943e3 · Cited by 128

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

Trinder, M., Walley, K. R., Boyd, J. H., & Brunham, L. R. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313381 · Cited by 126

Never waste a good crisis: confronting reproducibility in translational research

Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.006 · Cited by 117

Type 1 diabetes onset triggered by COVID-19

Marchand, L., Pecquet, M., & Luyton, C. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01570-0 · Cited by 116

Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis

Klonoff, D. C., Messler, J., Umpierrez, G. E., Peng, L., Booth, R., Crowe, J., Garrett, V., McFarland, R., & Pasquel, F. J. (2020) · Diabetes Care · doi:10.2337/dc20-1857 · Cited by 115

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study

Lampasona, V., Secchi, M., Scavini, M., Bazzigaluppi, E., Brigatti, C., Marzinotto, I., Davalli, A. M., Caretto, A., Laurenzi, A., Martinenghi, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05284-4 · Cited by 115

A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children

Hippich, M., Holthaus, L., Assfalg, R., Zapardiel‐Gonzalo, J., Kapfelsperger, H., Heigermoser, M., Haupt, F., Ewald, D., Welzhofer, T., Marcus, B. A., et al. (2020) · Med · doi:10.1016/j.medj.2020.10.003 · Cited by 111

Expansion of Pathogen-Specific T-Helper 1 and T-Helper 17 Cells in Pulmonary Tuberculosis With Coincident Type 2 Diabetes Mellitus

Kumar, N. P., Sridhar, R., Banurekha, V. V., Jawahar, M. S., Nutman, T. B., & Babu, S. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit241 · Cited by 110

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019

Agarwal, S., Schechter, C. B., Southern, W. N., Crandall, J. P., & Tomer, Y. (2020) · Diabetes Care · doi:10.2337/dc20-1543 · Cited by 107

Lack of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Large Cohort of Previously Infected Persons

Petersen, L. R., Sami, S., Vuong, N., Pathela, P., Weiss, D., Morgenthau, B. M., Henseler, R. A., Daskalakis, D., Atas, J. G., Patel, A. K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1685 · Cited by 106

Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID‐19 pandemic

Lawrence, C. M., Seckold, R., Smart, C. E., King, B. R., Howley, P., Feltrin, R., Smith, T. A., Roy, R., & Lopez, P. E. (2020) · Diabetic Medicine · doi:10.1111/dme.14417 · Cited by 104

Obesity and malnutrition similarly alter the renin–angiotensin system and inflammation in mice and human adipose

Pinheiro, T. D. A., Barcala-Jorge, A. S., Andrade, J. M. O., Pinheiro, T. D. A., Ferreira, E. C. N., Crespo, T. S., Batista-Jorge, G. C., Vieira, C. A., Lelis, D. D. F., Paraíso, A. F., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.06.008 · Cited by 103

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Perez-Belmonte, L. M., Torres-Peña, J. D., Lopez-Carmona, M. D., Ayala-Gutiérrez, M. M., Fuentes, F. J., Huerta, L. D. J., Muñoz, J. A., Rubio‐Rivas, M., Madrazo, M., García, M. G., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01832-2 · Cited by 103

Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19

Saeed, O., Castagna, F., Agalliu, I., Xue, X., Patel, S. R., Rochlani, Y. M., Kataria, R., Vukelic, S., Sims, D. B., Alvarez, C., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018475 · Cited by 101

Obesity as a risk factor for COVID ‐19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease

Peters, S. A. E., MacMahon, S. W., & Woodward, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14199 · Cited by 100

Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients

Czernichow, S., Beeker, N., Rives‐Lange, C., Guérot, E., Diehl, J., Katsahian, S., Hulot, J., Poghosyan, T., Carette, C., & Jannot, A. (2020) · Obesity · doi:10.1002/oby.23014 · Cited by 96

Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study

Cariou, B., Goronflot, T., Rimbert, A., Boullu, S., May, C. L., Moulin, P., Pichelin, M., Potier, L., Smati, S., Sultan, A., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.10.001 · Cited by 89

Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans

Baggio, L. L., Varin, E. M., Koehler, J. A., Cao, X., Lokhnygina, Y. V., Stevens, S. R., Holman, R. R., & Drucker, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17556-z · Cited by 83

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience

Duarte‐Salles, T., Vizcaya, D., Pistillo, A., Casajust, P., Sena, A. G., Lai, L. Y. H., Prats‐Uribe, A., Ahmed, W., Alshammari, T. M., Alghoul, H., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-042929 · Cited by 83

Relationship between obesity and severe COVID ‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

Smati, S., Tramunt, B., Wargny, M., Caussy, C., Gaborit, B., Vatier, C., Vergès, B. L., Ancelle, D., Amadou, C., Bachir, L. A., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14228 · Cited by 80

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

Dalan, R., Ang, L. W., Tan, W. Y. T., Fong, S., Tay, W. C., Chan, Y., Rénia, L., Ng, L. F. P., Lye, D. C., Chew, D. E. K., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa098 · Cited by 79

Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients

Masana, L., Correig, E., Rodríguez-Borjabad, C., Anoro, E., Arroyo, J. A., Jericó, C. R., Pedragosa, À., Miret, M., Näf, S., Pardo, A., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa128 · Cited by 78

Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series

Armeni, E., Aziz, U., Qamar, S., Nasir, S., Nethaji, C., Negus, R. P. M., Murch, N., Beynon, H. C., Bouloux, P. M., Rosenthal, M. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30221-7 · Cited by 77

Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates

Boonyaratanakornkit, J. B., Morishima, C., Selke, S., Zamora, D., McGuffin, S. A., Shapiro, A. E., Campbell, V. L., McClurkan, C. L., Jing, L., Gross, R., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144930 · Cited by 74

Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study

Butt, J. H., Gerds, T. A., Schou, M., Kragholm, K. H., Phelps, M. D., Havers‐Borgersen, E., Yafasova, A., Gislason, G., Torp-Pedersen, C. T., Køber, L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-044421 · Cited by 69

Identification of drugs associated with reduced severity of COVID-19 – a case-control study in a large population

Israel, A., Schäffer, A. A., Cicurel, A., Feldhamer, I., Tal, A., Cheng, K., Sinha, S., Schiff, E., Lavie, G., & Ruppin, E. (2021) · eLife · doi:10.7554/elife.68165 · Cited by 68

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19

Rhee, S. Y., Lee, J.-W., Nam, H., Kyoung, D., Shin, D. W., & Kim, D. J. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0206 · Cited by 64

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil

Borges, L. P., Martins, A. F., Seabra, M. S. D. M., de Oliveira, M. G. B., Neto, J. M. D. R., Dósea, M., Cabral, B. C. M., Menezes, R. F., Santos, A. A., Matos, I. L. S., et al. (2020) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2020.108 · Cited by 61

Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection

Feng, Q., Wei, W., Chaugai, S., Leon, B. G. C., Mosley, J. D., Leon, D. A. C., Jiang, L., Ihegword, A., Shaffer, C. M., Linton, M. F., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7223 · Cited by 61

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

Alzaïd, F., Julla, J., Diedisheim, M., Potier, C., Potier, L., Velho, G., Gaborit, B., Manivet, P., Germain, S., Vidal-Trécan, T., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013038 · Cited by 61

Children and youth with diabetes are not at increased risk for hospitalization due to COVID ‐19

Cardona‐Hernandez, R., Cherubini, V., Iafusco, D., Schiaffini, R., Luo, X., & Maahs, D. M. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13158 · Cited by 60

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus–induced type 2 responses and immunopathology

Bloodworth, M. H., Rusznak, M., Pfister, C. C., Zhang, J., Bastarache, L. A., Calvillo, S. A., Chappell, J. D., Boyd, K. L., Toki, S., Newcomb, D. C., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.053 · Cited by 58

Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors

Taneera, J., El‐Huneidi, W., Hamad, M. A., Mohammed, A. K., Elaraby, E., & Hachim, M. Y. (2020) · Biology · doi:10.3390/biology9080215 · Cited by 56

Diabetes-Related Major and Minor Amputation Risk Increased During the COVID-19 Pandemic

Casciato, D. J., Yancovitz, S., Thompson, J. C., Anderson, S., Bischoff, A. J., Ayres, S., & Barron, I. (2020) · Journal of the American Podiatric Medical Association · doi:10.7547/20-224 · Cited by 56

Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City

Altonen, B. L., Arreglado, T. M., Leroux, O., Murray-Ramcharan, M., & Engdahl, R. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243343 · Cited by 55

Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank

Scalsky, R. J., Desai, K., Chen, Y., O’Connell, J. R., Perry, J. A., & Hong, C. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248602 · Cited by 54

The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico

Woolcott, O. O., & Castilla-Bancayán, J. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88014-z · Cited by 54

Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history

Cai, Y., Shi, S., Yang, F., Yi, B., Chen, X., Li, J., & Wen, Z. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108437 · Cited by 52

Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters

Alahmad, B., Al‐Shammari, A. A., Bennakhi, A., Al‐Mulla, F., & Ali, H. (2020) · Diabetes Care · doi:10.2337/dc20-1941 · Cited by 52

Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19

Aparisi, Á., Iglesias-Echeverría, C., Ybarra-Falcón, C., Cusácovich, I., Uribarri, A., García-Gómez, M., Ladrón, R., Fuertes, R., Candela, J., Tobar, J., et al. (2021) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.06.016 · Cited by 48

ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19

Moustafa, J. S. E.-S., Jackson, A., Brotman, S. M., Guan, L., Villicaña, S., Roberts, A. L., Zito, A., Bonnycastle, L. L., Erdos, M. R., Narisu, N., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01136-w · Cited by 48

The Impact of Previous History of Bariatric Surgery on Outcome of COVID-19. A Nationwide Medico-Administrative French Study

Iannelli, A., Bouam, S., Schneck, A., Frey, S., Zarca, K., Gugenheim, J., & Alifano, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05120-z · Cited by 47

Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection

McPadden, J., Warner, F. J., Young, H. P., Hurley, N. C., Pulk, R., Singh, A., Durant, T. J. S., Gong, G., Desai, N. R., Haimovich, A. D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0243291 · Cited by 47

Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis

Chamorro-Pareja, N., Parthasarathy, S., Annam, J., Hoffman, J., Coyle, C., & Kishore, P. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154301 · Cited by 46

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study

Wargny, M., Gourdy, P., Ludwig, L., Seret‐Bégué, D., Bourron, O., Darmon, P., Amadou, C., Pichelin, M., Potier, L., Thivolet, C. H., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1217 · Cited by 46

Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19Preprint

Gupta, A., Madhavan, M. V., Poterucha, T. J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-56210/v1 · Cited by 46

Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID ‐19: A population‐based retrospective cohort study

Sainsbury, C. A. R., Wang, J., Gokhale, K. M., Acosta, D., Dhalla, S., Byne, N., Chandan, J. S., Anand, A., Cooper, J. M., Okoth, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14203 · Cited by 43

How obesity could create problems for a COVID vaccine

Ledford, H. K. (2020) · Nature · doi:10.1038/d41586-020-02946-6 · Cited by 41

ISARIC COVID-19 Clinical Data Report: Final report January 2020 – January 2023Preprint

Baillie, J. K., Baruch, J., Beane, A., Blumberg, L. H., Bozza, F. A., Broadley, T., Burrell, A. J. C., Carson, G., Citarella, B. W., Dunning, J. W., et al. (2020) · medRxiv · doi:10.1101/2020.07.17.20155218 · Cited by 41

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

Shields, A. M., Faustini, S. E., Pérez-Toledo, M., Jossi, S. E., Allen, J. D., Al‐Taei, S., Backhouse, C., Dunbar, L., Ebanks, D., Emmanuel, B., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000872 · Cited by 40

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

Schlicht, K., Rohmann, N., Geisler, C., Hollstein, T., Knappe, C., Hartmann, K., Schwarz, J., Tran, F., Schunk, D., Junker, R., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00689-y · Cited by 37

Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19

Riahi, S., Sombra, L. R. S., Lo, K. B., Chacko, S. R., Neto, A. G. M., Azmaiparashvili, Z., Patarroyo‐Aponte, G., Rangaswami, J., & Anastasopoulou, C. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1856865 · Cited by 37

Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium

Kasela, S., Ortega, V. E., Martorella, M., Garudadri, S., Nguyen, J., Ampleford, E., Pasanen, A., Nerella, S., Buschur, K. L., Barjaktarevic, I. Z., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00866-2 · Cited by 37

Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study

Moon, S. J., Rhee, E., Jung, J., Han, K., Kim, S.-R., Lee, W., & Yoon, K. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0141 · Cited by 36

A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2

Xi, C., Fazio, A. D., Nadvi, N. A., Patel, K., Xiang, M. S. W., Zhang, H. E., Deshpande, C. N., Low, J. K. K., Wang, X. T., Chen, Y., et al. (2020) · Molecules · doi:10.3390/molecules25225392 · Cited by 36

Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients

Buetti, N., Trimboli, P., Mazzuchelli, T., Priore, E. L., Balmelli, C., Trkola, A., Conti, M., Martinetti, G., Elzi, L., Ceschi, A., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02465-4 · Cited by 35

Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study

Mamtani, M., Athavale, A. M., Abraham, M., Vernik, J., Amarah, A., Ruíz, J. P., Joshi, A. J., Itteera, M., Zhukovsky, S., Madaiah, R. P., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101254 · Cited by 33

The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes

Huang, Y., Guo, H., Zhou, Y., Guo, J., Wang, T., Zhao, X., Li, H., Sun, Y., Bian, X., & Fang, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108448 · Cited by 32

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019

Huang, M., Lu, Q., Zhao, H., Zhang, Y., Sui, Z., Fang, L., Liu, D., Sun, X., Peng, K., Liu, W. Y., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00209-2 · Cited by 31

Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?

Soldo, J., Heni, M., Königsrainer, A., Häring, H., Birkenfeld, A. L., & Peter, A. (2020) · Diabetes Care · doi:10.2337/dc20-1458 · Cited by 31

MicroRNA-106 attenuates hyperglycemia-induced vascular endothelial cell dysfunction by targeting HMGB1

Liu, R., Luo, Q., You, W., & Jin, M. (2018) · Gene · doi:10.1016/j.gene.2018.07.063 · Cited by 30

No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19

Zhou, J., Wu, B., Wang, W., Lei, F., Cheng, X., Qin, J., Cai, J., Zhang, X., Zhou, F., Liu, Y.-M., et al. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i22.5576 · Cited by 30

Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19 Patients

Savarraj, J. P. J., Burkett, A., Hinds, S. N., Paz, A. S., Assing, A., Juneja, S., Colpo, G. D., Torres, L. F., Cho, S., Gusdon, A. M., et al. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.737961 · Cited by 30

GLP-1 Receptor Signaling Differentially Modifies the Outcomes of Sterile vs Viral Pulmonary Inflammation in Male Mice

Sato, T., Shimizu, T., Fujita, H., Imai, Y., Drucker, D. J., Seino, Y., & Yamada, Y. (2020) · Endocrinology · doi:10.1210/endocr/bqaa201 · Cited by 29

Degree of hyperglycemia independently associates with hospital mortality and length of stay in critically ill, nondiabetic patients: Results from the ANZICS CORE binational registry

Mamtani, M., Kulkarni, H. R., Bihari, S., Prakash, S., Chavan, S., Huckson, S., & Pilcher, D. V. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.11.003 · Cited by 29

Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes

Chen, X., Chen, Y., Wu, C., Wei, M., Xu, J., Chao, Y.-C., Song, J., Hou, D., Zhang, Y., Du, C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001851 · Cited by 29

SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients

Buetti, N., Wicky, P.-H., Hingrat, Q. L., Ruckly, S., Mazzuchelli, T., Loiodice, A., Trimboli, P., Ogna, V. F., de Montmollin, É., Bernasconi, E., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03323-5 · Cited by 28

Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)

Joshi, S. S., Davis, R. P., Ma, M. M., Tam, E., Cooper, C., Ramji, A. S., Kelly, E., Jayakumar, S., Swain, M. G., Jenne, C. N., et al. (2021) · npj Vaccines · doi:10.1038/s41541-020-00266-4 · Cited by 28

No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes

Vangoitsenhoven, R., Martens, P.-J., van Nes, F., Moyson, C., Nobels, F. R. E., Crombrugge, P. V., Wierckx, K., Pottelbergh, I. V., Huffel, L. V., Gillard, P., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1246 · Cited by 26

Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker–Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19

Admin, A., Batchu, S. N., Kaur, H., Yerra, V. G., Advani, S. L., Kabir, G., Liu, Y., Klein, T., & Advani, A. (2020) · Diabetes · doi:10.2337/db20-0765 · Cited by 26

Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages

Sosa-Rubí, S. G., Seiglie, J. A., Chivardi, C., Manne‐Goehler, J., Meigs, J. B., Wexler, D. J., Wirtz, V. J., Gómez‐Dantés, O., & Servan-Mori, E. E. (2020) · Diabetes Care · doi:10.2337/dc20-2192 · Cited by 25

Epidemiological and Immunological Features of Obesity and SARS-CoV-2

Nilles, E. J., Siddiqui, S. M., Fischinger, S., Bartsch, Y. C., Aubin, M. D. S., Zhou, G., Gluck, M. J., Berger, S., Rhee, J., Petersen, E., et al. (2021) · Viruses · doi:10.3390/v13112235 · Cited by 23

Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 InfectionPreprint

McPadden, J., Warner, F. J., Young, H. P., et al. (2020) · medRxiv · doi:10.1101/2020.07.19.20157305 · Cited by 21

The active GLP-1 analogue liraglutide alleviates H9N2 influenza virus-induced acute lung injury in mice

Bai, Y., Lian, P., Li, J., Zhang, Z., & Jian, Q. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104645 · Cited by 19

COVID-19 outcomes in UK centre within highest health and wealth band: a prospective cohort study

Ken‐Dror, G., Wade, C., Sharma, S. S., Law, J. K., Russo, C., Sharma, A., Joy, E., John, J., Robin, J. G., John, S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-042090 · Cited by 16

A Time Frame for Testing Negative for SARS-COV2 in People with Obesity

Dicker, D., Lev, S., Gottesman, T., Kournos, T., Dotan, M., Ashorov, N., Marcoviciu, D., & Golan, R. (2020) · Obesity Facts · doi:10.1159/000511738 · Cited by 12

Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study.

Cariou, B., Goronflot, T., Rimbert, A., Boullu, S., May, C. L., Moulin, P., Pichelin, M., Potier, L., Smati, S., Sultan, A., et al. (2020) · Diabetes & Metabolism · Cited by 12

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary carePreprint

Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2020) · medRxiv · doi:10.1101/2020.10.25.20200675 · Cited by 11

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United StatesPreprint

Burn, E., Sena, A. G., Prats‐Uribe, A., Spotnitz, M., DuVall, S. L., Lynch, K. E., Matheny, M. E., Nyberg, F., Ahmed, W., Alser, O. H., et al. (2020) · medRxiv · doi:10.1101/2020.11.25.20229088 · Cited by 10

Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort analysis including 2,524,926 people in Catalonia, SpainPreprint

Recalde, M., Pistillo, A., Fernández‐Bertolín, S., Roel, E., Aragón, M., Freisling, H., Prieto‐Alhambra, D., Burn, E., & Duarte‐Salles, T. (2020) · medRxiv · doi:10.1101/2020.11.25.20237776 · Cited by 6

Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus

Cevallos, E. C., Campioli, C. C., & O’Horo, J. C. (2020) · Endocrine · doi:10.1007/s12020-020-02516-w · Cited by 6

Female gender is associated with long COVID syndrome: a prospective cohort study

Bai, F., Tomasoni, D., Falcinella, C., Barbanotti, D., Castoldi, R., Mulè, G., Augello, M., Mondatore, D., Allegrini, M., Cona, A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.002 · Cited by 644

Immune cell-mediated features of non-alcoholic steatohepatitis

Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 300

Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

Zhou, X., Chen, Q., Yang, W., Zuluaga, M., Targher, G., Byrne, C. D., Valenti, L. V. C., Luo, F., Katsouras, C. S., Thaher, O., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102848 · Cited by 269

Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine

Pellini, R., Venuti, A., Pimpinelli, F., Abril, E., Blandino, G., Campo, F., Conti, L., VIRGILIO, A. D., Marco, F. D., Domenico, E. G. D., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100928 · Cited by 237

Pathophysiologic Processes, Correlates and Comorbidities of Obesity and Type 2 Diabetes Evidenced in the SARS-CoV-2/COVID-19 Pandemic

Chukwuma, C. (2025) · Mathews Journal of Diabetes & Obesity · doi:10.30654/mjdo.10023 · Cited by 2

UNDERSTANDING THE PATHOPHYSIOLOGIC MECHANISMS AND INTERPLAY BETWEEN SARS-CoV-2 /COVID-19, OBESITY AND DIABETES WITH INCURSIONS INTO THE POST-PANDEMIC ERA

Chrysanthus, C. S. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.18045918

INSIGHTS FOR CLINICAL INTERVENTIONS AND PUBLIC HEALTH STRATEGIES IN OBESITY AND DIABETES ASSOCIATED WITH THE COVID-19

Sr*, D. C. C. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.17909208

Diabetes Mellitus, Energy Metabolism, and COVID-19

Conte, C., Cipponeri, E., & Roden, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad032 · Cited by 51

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle

Holly, J. M. P., Biernacka, K. M., Maskell, N. A., & Perks, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.582870 · Cited by 56